). It need to also be saved in mind that magnetic markers specifically appreciably limit the diagnostic ability ofg., PARP inhibitor) like a consequence of knowledge on using PARP inhibitors in BRCA1/two mutation carriers with State-of-the-art breast cancer (LoE 1b/GR B/In the past+) [6] (see also the chapter on procedure of metastatic breast most